CAR-T cell therapy shows promise for rare autoimmune disorder in clinical trial.
Cartesian Therapeutics' experimental CAR-T cell therapy shows promise in treating Myasthenia Gravis, a disease where the immune system attacks and destroys the junctions between nerves and muscles. A North Carolina forester suffering from the disease found hope in the treatment after struggling with leg and arm weakness.